NEW YORK, July 29 (GenomeWeb News) - Sequenom announced today that it has terminated its internal drug discovery efforts and will shut down its pharmaceuticals business unit in an effort to focus on its genetics systems business unit.
Registering provides access to this and other free content.
Already have an account?Login Now.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.